The IVI-NSCLC model is coming

The Innovation and Value Initiative today announced that it is in the process of releasing a new model and value tool to evaluate treatments for for EGFR-positive non-small cell lung cancer (NSCLC).  More details on the model (named the IVI-NSCLC model) are available here, which includes a study protocol and model timeline.

Oncology is an area of immense clinical need and a primary driver of healthcare spending, making it a prime target for assessment of the value of available medical interventions. IVI’s next Open-Source Value Project (OSVP) model will focus on non-small cell lung cancer (NSCLC). Specifically, the IVI-NSCLC model will focus on sequential treatment strategies for patients with epidermal growth factor receptor positive (EGFR+) NSCLC.

IVI’s open-source value model for EGFR+ NSCLC treatments will facilitate patient-centered, robust, and relevant evaluation of the value of care for an often devastating disease. Development of this model reflects IVI’s vision of a transparent process for understanding value in the local setting, especially from the patient perspective.

The full model and value tool are due out to the public November 29 according to the IVI-NSCLC timeline.

from Dental Tips https://www.healthcare-economist.com/2018/08/23/the-ivi-nsclc-is-coming/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s